Anticancer palladium-doped magnesia nanoparticles: synthesis, characterization, and in vitro study
Abstract
Aim: To prepare, physicochemically characterize and determine the anticancer effects of palladium-doped magnesia (Pd/MgO) nanoparticles. Materials & methods: Pd/MgO nanoparticles were prepared by the co-precipitation method from the aqueous solution of Mg(NO3)2.6H2O using K2CO3 and the impregnation of MgO into palladium acetylacetonate. Results: Pd/MgO nanoparticles were between 47 and 70 nm in size, cuboid in shape, and tended to form aggregates. Nanoparticles were more antiproliferative toward cancer than the normal cells. In cancer cells, Pd/MgO nanoparticles induced apoptosis by increasing caspase activities and stimulating cytochrome C release. The anticancer effects of Pd/MgO nanoparticles were accentuated by the upregulation of Bax and p53 and downregulation of Bcl-2 protein expressions. Conclusion: Pd/MgO nanoparticles have potential to be developed as an anticancer compound.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics. OUP, Oxford, UK (2012).
- 2. . Molecular Biology of Cancer. Taylor & Francis, London, UK (2004).
- 3. . Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells. Molecules 16(4), 2944–2959 (2011).
- 4. Characterization of thymoquinone/hydroxypropyl-β-cyclodextrin inclusion complex: application to anti-allergy properties. Eur. J. Pharm. Sci. 133, 167–182 (2019). •• Shows serious issue of poor aqueous solubility of drugs in medical application and development of anticancer compounds.
- 5. . Metals in Medicine. Wiley, West Sussex, UK (2013).
- 6. . Cisplatin: Current Status and New Developments. Elsevier Science, NY, USA 445–458 (2013).
- 7. . Noble metals in oncology. Contemp. Oncol. 19(4), 271 (2015). • Determines the role and mechanism of noble metals in cancer treatment and their limitations.
- 8. . Structure, recognition, and processing of cisplatin − DNA adducts. Chem. Rev. 99(9), 2467–2498 (1999).
- 9. Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin. Cancer Res. 10(4), 1318–1325 (2004).
- 10. . Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. J. Bioenerg. Biomembr. 39(1), 43–50 (2007).
- 11. . D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear. Res. 102(1–2), 90–98 (1996).
- 12. . Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines. Cancer Chemother. Pharmacol. 45(1), 43–49 (2000). • Reveals the serious side effects of chemotherapies on human health, which in turn encourage ongoing search for more selective anticancer drugs with minimal side effects.
- 13. . Cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. Biomaterials 34(4), 1372–1382 (2013). •• Nanotechnology and nanomedicine are promising strategies employed in the development of anticancer drugs.
- 14. pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy. J. Adv. Res. 18, 161–172 (2019). •• Using transition metal oxide as drug carrier offers an improved, targeted tumor therapy strategy for cancer treatment without less side effect.
- 15. . Mechanism of setting reaction in magnesia-phosphate cements. Cement Concrete Res. 30(2), 315–321 (2000).
- 16. . Effects of platinum and palladium metals on Ni/Mg1-xZrxO catalysts in the CO2 reforming of methane. Bull. Chem. React. Eng. Catalysis 13(2), 295–310 (2018). •• The loading of transition metal oxide with palladium exhibit more active site on the nanoparticles surface.
- 17. Induction of apoptosis in cancer cells by NiZn ferrite nanoparticles through mitochondrial cytochrome C release. Int. J. Nanomed. 8, 4115–4130 (2013).
- 18. Cytotoxicity of nickel zinc ferrite nanoparticles on cancer cells of epithelial origin. Int. J. Nanomed. 8, 2497–2508 (2013).
- 19. . X-Ray Diffraction: A Practical Approach. Springer Science and Business Media, NY, USA (2013).
- 20. . Fourier Transform Infrared Spectroscopy (FTIR): Methods, Analysis and Research Insights. Nova Science Publishers, Inc., NY, USA (2016).
- 21. . Mechanochemical synthesis of metal sulphide nanoparticles. Nanostruct. Mater. 12(1–4), 75–78 (1999).
- 22.
US20060153728 (2006) - 23. . Influence of temperature and concentration on biosynthesis and characterization of zinc oxide nanoparticles using cherry extract. J. Nanostruct. Chem. 8(1), 93–102 (2018).
- 24. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Particle Fibre Toxicol. 5(1), 14 (2008). • Recommendation to reduce nanoparticle aggregation, which leads to increased drug efficacy.
- 25. . Cytotoxic effects of newly synthesized palladium (II) complexes of diethyldithiocarbamate on gastrointestinal cancer cell lines. Biochem. Res. Int. 2014, 813457–813457 (2014).
- 26. . Platinum (II) and palladium (II) complex compounds as anti-cancer drugs. Methods of cytotoxicity determination. Curr. Pharm. Analysis 10(1), 2–9 (2014). •• Good introduction for using palladium in cancer treatment and its side effects.
- 27. . Caspases: the executioners of apoptosis. Biochem. J. 326(1), 1–16 (1997).
- 28. . Caspases: killer proteases. Trends Biochem. Sci. 22(8), 299–306 (1997).
- 29. . Apoptosis: Physiology and Pathology. Cambridge University Press, NY, USA (2011).